Glenmark Pharmaceuticals Limited(IN:GLENMARK)
₹2,628.90-14.10 (-0.53%)
IN:GLENMARK
Glenmark Pharmaceuticals Limited Revenue
₹2,628.90
At close:-14.10 (-0.53%)
Want to see IN:GLENMARK full AI Analyst Report?
Glenmark Pharmaceuticals Limited (GLENMARK) Revenue
5 Followers
Glenmark Pharmaceuticals Limited Revenue
Glenmark Pharmaceuticals Limited had a revenue of 37.71B in the quarter ending Mar 31, 2026, with -3.33%. This bring the company's revenue in the last twelve months to 169.83B, Increased 3.50%. In the fiscal year ending Mar 31, 2026, Glenmark Pharmaceuticals Limited had annual revenue of 169.83B with 27.08% growth.
- Revenue (ttm)
- 169.83B
- Revenue Growth
- -0.11%
- P/S Ratio
- 4.39
- Revenue/Employee
- INR 10,021,545
- Employees
- 16,946
- Market Cap
- INR 745.92B
Revenue Chart
Glenmark Pharmaceuticals Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 169.83B | 36.19B | 27.08% |
| Mar 31, 2025 | 133.63B | 7.18B | 5.68% |
| Mar 31, 2024 | 126.45B | 9.90B | 8.49% |
| Mar 31, 2023 | 116.56B | -6.49B | -5.28% |
| Mar 31, 2022 | 123.05B | 13.61B | 12.44% |
| Mar 31, 2021 | 109.44B | 2.87B | 2.69% |
| Mar 31, 2020 | 106.57B | 7.92B | 8.03% |
| Mar 31, 2019 | 98.65B | 7.91B | 8.72% |
| Mar 31, 2018 | 90.74B | -49.95M | -0.06% |
| Mar 31, 2017 | 90.79B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:GLENMARK | 169.83B |
| IN:AUROPHARMA | 368.68B |
| IN:DRREDDY | 329.84B |
| IN:LUPIN | 306.79B |
| IN:SUNPHARMA | 616.31B |
| IN:ZYDUSLIFE | 303.78B |

